Please note: This website has recently moved from www.health.gov to odphp.health.gov. www.health.gov is now the official website of ODPHP’s parent organization, the Office of the Assistant Secretary for Health (OASH). Please update your bookmarks for easy access to all our resources. 

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication

About this resource:

Systematic Review

Source: U.S. Preventive Services Task Force

Last Reviewed: September 2014

Workgroups: Maternal, Infant, and Child Health Workgroup

The U.S. Preventive Services Task Force (USPSTF) recommends that women who are at a high risk for preeclampsia take a low dose of aspirin to reduce their risk of preeclampsia and the harm it causes. Specifically, USPSTF recommends that clinicians prescribe low-dose (81 mg per day) aspirin after 12 weeks of pregnancy to women with at least 1 of the following:

  • Had preeclampsia in a previous pregnancy
  • Are pregnant with more than one baby
  • Have chronic hypertension
  • Have type 1 or type 2 diabetes
  • Have kidney disease
  • Have certain autoimmune diseases
Read more about this resource

Objectives related to this resource (2)

Reduce maternal deaths — MICH‑04
LHI label
Getting worse
Reduce severe maternal complications identified during delivery hospitalizations — MICH‑05
Getting worse

Suggested Citation

1.

U.S. Preventive Services Task Force. (2014). Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication. Retrieved from https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication